ClinicalTrials.gov
ClinicalTrials.gov Menu

Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00916266
Recruitment Status : Completed
First Posted : June 9, 2009
Last Update Posted : July 31, 2015
Sponsor:
Collaborators:
Hospital Sao Lucas da PUCRS
Instituto do Cerebro da PUCRS
Information provided by (Responsible Party):
Jaderson Costa da Costa, Hospital Sao Lucas da PUCRS

Brief Summary:
This research investigates the use of autologous bone marrow stem cells for the treatment of medically refractory temporal lobe epilepsy patients.

Condition or disease Intervention/treatment Phase
Epilepsy Procedure: Stem cell transplantation Phase 1

Detailed Description:
The aim of this study is to evaluate autologous bone marrow stem cells transplantation as a safe and potentially beneficial treatment for patients with temporal lobe refractory epilepsy. We are mainly evaluating seizure frequency, hippocampal volume an cognitive performance

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Phase 1 Study of Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy
Study Start Date : July 2008
Actual Primary Completion Date : November 2011
Actual Study Completion Date : May 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Epilepsy Seizures

Arm Intervention/treatment
Experimental: stem cell transplantation
Patients with refractory temporal lobe epilepsy that are transplanted with autologous bone marrow stem cells in order to provide seizure control.
Procedure: Stem cell transplantation
Transplantations with autologous bone marrow mononuclear stem cells by selective posterior cerebral artery angiography
Other Name: BMMSC - Bone Marrow Mononuclear Stem Cells




Primary Outcome Measures :
  1. seizure frequency [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. adverse effects [ Time Frame: 6 months ]
  2. hippocampal volume [ Time Frame: 6 months ]
  3. cognitive performance [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • temporal lobe medically refractory epilepsy patients with hippocampal atrophy

Exclusion Criteria:

  • under 18 or over 65 years old patients
  • previous neurological surgery
  • other neurodegenerative diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00916266


Locations
Brazil
Instituto do Cerebro
Porto Alegre, RS, Brazil
Sponsors and Collaborators
Instituto do Cerebro de Brasilia
Hospital Sao Lucas da PUCRS
Instituto do Cerebro da PUCRS
Investigators
Principal Investigator: Jaderson C da Costa, MD, PhD Instituto do Cerebro-PUCRS

Publications:

Responsible Party: Jaderson Costa da Costa, MD, PhD, Hospital Sao Lucas da PUCRS
ClinicalTrials.gov Identifier: NCT00916266     History of Changes
Other Study ID Numbers: Stem cells in Epilepsy
First Posted: June 9, 2009    Key Record Dates
Last Update Posted: July 31, 2015
Last Verified: July 2015

Keywords provided by Jaderson Costa da Costa, Hospital Sao Lucas da PUCRS:
Seizure frequency
Hippocampal volume
Adverse effects

Additional relevant MeSH terms:
Epilepsy
Epilepsy, Temporal Lobe
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Epilepsies, Partial